Medirom Healthcare Technologies Stock Probability of Future Stock Price Finishing Over 3.02
| MRM Stock | USD 3.02 0.22 6.79% |
Medirom |
Medirom Healthcare Target Price Odds to finish over 3.02
The tendency of Medirom Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 3.02 | 90 days | 3.02 | about 82.25 |
Based on a normal probability distribution, the odds of Medirom Healthcare to move above the current price in 90 days from now is about 82.25 (This Medirom Healthcare Technologies probability density function shows the probability of Medirom Stock to fall within a particular range of prices over 90 days) .
Considering the 90-day investment horizon the stock has the beta coefficient of 3.54 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Medirom Healthcare will likely underperform. Additionally Medirom Healthcare Technologies has an alpha of 0.1313, implying that it can generate a 0.13 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Medirom Healthcare Price Density |
| Price |
Predictive Modules for Medirom Healthcare
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Medirom Healthcare. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Medirom Healthcare's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Medirom Healthcare Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Medirom Healthcare is not an exception. The market had few large corrections towards the Medirom Healthcare's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Medirom Healthcare Technologies, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Medirom Healthcare within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.13 | |
β | Beta against Dow Jones | 3.54 | |
σ | Overall volatility | 0.80 | |
Ir | Information ratio | 0.02 |
Medirom Healthcare Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Medirom Healthcare for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Medirom Healthcare can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Medirom Healthcare is way too risky over 90 days horizon | |
| Medirom Healthcare appears to be risky and price may revert if volatility continues | |
| Medirom Healthcare has high likelihood to experience some financial distress in the next 2 years | |
| Medirom Healthcare Technologies has 2.89 B in debt. Medirom Healthcare has a current ratio of 0.35, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Medirom to invest in growth at high rates of return. | |
| Medirom Healthcare Technologies has about 354.95 M in cash with (631.74 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 72.7, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Medirom Healthcare has a poor financial position based on the latest SEC disclosures | |
| Roughly 40.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from globenewswire.com: Mrm SCOR, MRMs reference shareholder, announced its intent to acquire all the remaining shares of MRM through a simplified public tender offer followed, if conditions are met, by a squeeze-out |
Medirom Healthcare Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Medirom Stock often depends not only on the future outlook of the current and potential Medirom Healthcare's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Medirom Healthcare's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 5.2 M | |
| Cash And Short Term Investments | 106.8 M |
Medirom Healthcare Technical Analysis
Medirom Healthcare's future price can be derived by breaking down and analyzing its technical indicators over time. Medirom Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Medirom Healthcare Technologies. In general, you should focus on analyzing Medirom Stock price patterns and their correlations with different microeconomic environments and drivers.
Medirom Healthcare Predictive Forecast Models
Medirom Healthcare's time-series forecasting models is one of many Medirom Healthcare's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Medirom Healthcare's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Medirom Healthcare
Checking the ongoing alerts about Medirom Healthcare for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Medirom Healthcare help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Medirom Healthcare is way too risky over 90 days horizon | |
| Medirom Healthcare appears to be risky and price may revert if volatility continues | |
| Medirom Healthcare has high likelihood to experience some financial distress in the next 2 years | |
| Medirom Healthcare Technologies has 2.89 B in debt. Medirom Healthcare has a current ratio of 0.35, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Medirom to invest in growth at high rates of return. | |
| Medirom Healthcare Technologies has about 354.95 M in cash with (631.74 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 72.7, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Medirom Healthcare has a poor financial position based on the latest SEC disclosures | |
| Roughly 40.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from globenewswire.com: Mrm SCOR, MRMs reference shareholder, announced its intent to acquire all the remaining shares of MRM through a simplified public tender offer followed, if conditions are met, by a squeeze-out |
Additional Information and Resources on Investing in Medirom Stock
When determining whether Medirom Healthcare is a strong investment it is important to analyze Medirom Healthcare's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Medirom Healthcare's future performance. For an informed investment choice regarding Medirom Stock, refer to the following important reports:Check out Medirom Healthcare Backtesting, Medirom Healthcare Valuation, Medirom Healthcare Correlation, Medirom Healthcare Hype Analysis, Medirom Healthcare Volatility, Medirom Healthcare History as well as Medirom Healthcare Performance. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medirom Healthcare. If investors know Medirom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medirom Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.582 | Earnings Share 0.15 | Revenue Per Share 1.4 K | Quarterly Revenue Growth (0.06) | Return On Assets (0.04) |
The market value of Medirom Healthcare is measured differently than its book value, which is the value of Medirom that is recorded on the company's balance sheet. Investors also form their own opinion of Medirom Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Medirom Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medirom Healthcare's market value can be influenced by many factors that don't directly affect Medirom Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medirom Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medirom Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medirom Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.